Durvalumab plus platinum-etoposide in extensive-stage extrapulmonary small cell carcinoma (ES-EPSCC): Second safety assessment of the DURVASCC trial (GOIRC-01-2021).
Year: 2026
Type: conference-abstract
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Institutions: University of Parma, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, European Institute of Oncology, Azienda Sanitaria Unità Locale di Reggio Emilia, Fondazione IRCCS Istituto Nazionale dei Tumori, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Centro di Riferimento Oncologico, Azienda Ospedaliero-Universitaria di Modena, University of Pisa, Azienda Ospedaliera Universitaria Pisana
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162682929
Cites:
Cited by:
Related to: